Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Endoscopic Ultrasound (EUS) Market by Product (Endoscope, Needle, Ultrasound Processor, Accessories), by Application (Gastrointestinal Cancer, Lung Cancer, Pancreaticobiliary Cancer, Others), by End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), by North America (USA, Canada, Mexico), by Europe (Germany, UK, France, Italy, Spain), by Asia Pacific (China, Japan, India, South Korea, Australia), by Latin America (Brazil, Argentina), by Middle East & Africa (South Africa, Saudi Arabia) Forecast 2026-2034
Updated On : Oct 28, 2026|Base Year : 2025|Pages : 300
The global endoscopic ultrasound (EUS) market is experiencing robust expansion, driven by the rising incidence of gastrointestinal and pancreaticobiliary cancers and a paradigm shift toward minimally invasive diagnostic and therapeutic procedures. Our proprietary primary research estimates the market at USD 1.6 billion in 2025, with a projected valuation of USD 2.8 billion by 2033, representing a steady CAGR of 7.1% during the forecast period (2026–2033). North America currently dominates the landscape, holding a 31.0% revenue share in 2025, while the Asia Pacific region is identified as the fastest-growing market due to improving healthcare infrastructure and increasing cancer awareness.
Endoscopic Ultrasound (EUS) Market Size (In Billion)
2.5B
2.0B
1.5B
1.0B
500.0M
0
1.600 B
2025
1.714 B
2026
1.835 B
2027
1.966 B
2028
2.105 B
2029
2.255 B
2030
2.415 B
2031
EUS technology integrates high-frequency ultrasound imaging with flexible endoscopy, enabling real-time visualization of the GI tract wall and adjacent organs. This capability is indispensable for accurate tumor staging, tissue sampling via fine-needle aspiration (FNA), and an expanding array of interventional procedures. The market is characterized by continuous technological innovation, including AI-assisted image interpretation, contrast-enhanced imaging, and the development of specialized echoendoscopes and biopsy needles.
Market Dynamics: Drivers, Restraints, and Trends
The EUS market is propelled by a confluence of clinical, technological, and demographic factors. However, significant barriers to adoption remain, particularly in resource-constrained settings.
Key Growth Drivers
Rising Cancer Burden: The escalating global incidence of gastrointestinal and pancreaticobiliary cancers is a fundamental driver. According to the International Agency for Research on Cancer (IARC), approximately 20 million new cancer cases were diagnosed in 2022, with projections reaching 35 million by 2050. EUS is a cornerstone for diagnosing and staging these malignancies, particularly pancreatic cancer, where it is often the preferred modality for tissue acquisition.
Shift Toward Minimally Invasive Procedures: There is a strong clinical and patient preference for minimally invasive techniques that reduce recovery times and morbidity compared to surgical alternatives. EUS-guided interventions, such as drainage of pancreatic fluid collections and biliary access, are increasingly replacing more invasive surgical procedures.
Technological Advancements: Continuous innovation is expanding the clinical utility of EUS. Recent developments include high-resolution imaging, elastography, and AI-assisted lesion characterization, which improve diagnostic accuracy. The introduction of lumen-apposing metal stents (LAMS) has further broadened therapeutic applications.
Expanding Applications in Lung Cancer Staging: The adoption of endobronchial ultrasound (EBUS) for minimally invasive lung cancer staging is rapidly growing, significantly contributing to overall EUS market expansion.
Key Market Restraints
High Cost of Advanced Systems: The substantial capital investment required for EUS systems, including echoendoscopes and processors, poses a significant barrier, particularly for smaller hospitals and clinics in emerging economies.
Requirement for Specialized Expertise: EUS is a technically demanding procedure requiring extensive training and experience. The global shortage of skilled endoscopists limits widespread adoption and market growth.
Reimbursement Challenges: In some regions, inadequate or inconsistent reimbursement policies for EUS procedures can hinder adoption.
Key Market Trends
Integration of Artificial Intelligence: AI algorithms are being developed to assist with real-time image interpretation, lesion detection, and diagnostic support, enhancing procedural efficiency and accuracy.
Growth of Interventional EUS: The shift from diagnostic to therapeutic EUS is a major trend, with procedures like EUS-guided gastroenterostomy and gallbladder drainage gaining traction.
Development of Dedicated Devices: Manufacturers are focusing on creating specialized accessories, such as fine-needle biopsy (FNB) needles designed to improve tissue yield and diagnostic accuracy.
Segmentation Analysis: Products, Applications, and End Users
Our analysis segments the EUS market by product type, application, and end-use setting, providing a granular view of revenue distribution and growth potential.
By Product
The endoscope segment dominates the market, accounting for 33.9% of revenue in 2025. This is driven by the essential nature of echoendoscopes (both radial and linear) in all EUS procedures. The needle segment is expected to witness significant growth due to the rising volume of FNA/FNB procedures and the introduction of advanced biopsy needles. Other accessory segments include ultrasound processors, guidewires, and dilation devices.
Product Category
2025 Revenue Share
Key Growth Factors
Endoscopes (Radial/Linear)
33.9%
High replacement costs, technological upgrades, and essential procedural role.
Needles (FNA/FNB)
~25%
Increasing cancer diagnostics, shift toward FNB for better tissue yield.
Ultrasound Processors
~20%
Integration of AI and advanced imaging software.
Accessories (Stents, Guidewires)
Remaining
Growth in interventional EUS procedures.
By Application
The lung cancer segment leads with a 42.1% share in 2025, largely due to the high volume of EBUS procedures for staging. The gastrointestinal cancer segment is another major application, encompassing esophageal, gastric, and colorectal cancers. The pancreaticobiliary segment is a critical and growing area, particularly for pancreatic cancer diagnosis and biliary interventions. Other applications include subepithelial lesions and inflammatory conditions.
By End Use
Hospitals are the primary end users, holding a 39.6% share in 2025. This is attributed to the high concentration of specialized gastroenterology departments and oncology centers. Ambulatory Surgical Centers (ASCs) are expected to grow at a faster rate due to the shift of lower-acuity procedures to outpatient settings and the increasing availability of advanced equipment in these facilities.
Regional Insights and Growth Opportunities
Geographic analysis reveals distinct patterns of adoption and growth, shaped by healthcare infrastructure, reimbursement landscapes, and disease prevalence.
North America
North America remains the largest market, with the U.S. holding the dominant share. This is driven by a high prevalence of cancer, well-established healthcare infrastructure, rapid adoption of advanced technologies, and favorable reimbursement policies. The presence of leading manufacturers and a strong focus on R&D further support market growth.
Europe
Europe is a mature market with steady growth, characterized by high healthcare expenditure and a strong emphasis on early cancer detection. Countries like Germany, the UK, and France are key contributors. The implementation of national cancer screening programs is expected to drive procedure volumes.
Asia Pacific
The Asia Pacific region is projected to be the fastest-growing market, fueled by a rapidly aging population, increasing healthcare expenditure, and rising awareness of minimally invasive procedures. Emerging economies such as China and India present significant untapped potential, with increasing investments in healthcare infrastructure and a growing number of trained endoscopists.
Latin America and Middle East & Africa
These regions are expected to experience moderate growth, driven by improving healthcare access and a rising burden of GI diseases. However, economic constraints and a shortage of skilled professionals may hinder faster adoption.
Competitive Landscape and Strategic Insights
The global EUS market is consolidated, with a few key players dominating the landscape. Our competitive analysis highlights the strategies of leading companies, including Olympus Corporation, Fujifilm Corporation, Boston Scientific Corporation, Pentax Medical, Cook Medical, Medtronic, ConMed, SonoScape, Medi-Globe, and B. Braun.
Major Players and Market Strategies
Olympus Corporation: A market leader with a broad portfolio of echoendoscopes and processors. The company focuses on continuous innovation, such as the launch of the EU-ME3 processor platform, and expanding its interventional EUS offerings.
Fujifilm Corporation: A strong competitor with advanced imaging technologies, including high-definition EUS and AI-assisted tools. Fujifilm is actively expanding its global footprint.
Boston Scientific Corporation: A key player in interventional EUS, particularly with its AXIOS stent system for EUS-guided drainage. The company's strategy emphasizes expanding clinical indications for its devices.
Cook Medical: Known for its comprehensive line of EUS needles and accessories, Cook Medical competes on product reliability and procedural support.
Medtronic and ConMed: These companies are leveraging their broad medical device portfolios to offer integrated solutions and drive adoption.
Emerging Players: Companies like SonoScape are gaining traction by offering cost-effective alternatives, particularly in price-sensitive emerging markets.
Recent Developments
2022: Olympus launched the EU-ME3 endoscopic ultrasound processor, enhancing diagnostic capabilities for pancreatic and GI cancers.
2023: Boston Scientific received FDA approval for expanded indications for its AXIOS stent system.
2024: Several companies announced partnerships with AI firms to integrate machine learning into EUS imaging platforms.
Value Chain and Supply Chain Analysis
The EUS value chain comprises R&D, component manufacturing, assembly, distribution, and end-user (hospitals, ASCs). The supply chain is characterized by high barriers to entry in manufacturing, given the precision engineering required for echoendoscopes and ultrasound processors. Key components include transducers, imaging sensors, and specialized biocompatible materials.
Supplier Dynamics: The production of advanced ultrasound transducers and processors is concentrated among a few specialized firms. Geopolitical tensions and trade regulations can impact the supply of critical components.
Procurement: Hospitals typically procure EUS systems through group purchasing organizations (GPOs) or direct negotiations. The replacement cycle for endoscopes is typically 5-7 years, creating a steady replacement demand.
Distributors: In many regions, manufacturers rely on local distributors for sales and service. Building strong distributor relationships is critical for market penetration.
Strategic White-Space and Investment Opportunities
Our analysis identifies several high-potential areas for investment and strategic growth:
AI-Enabled EUS Platforms: The integration of AI for real-time lesion detection and characterization represents a significant white space. Companies developing validated AI algorithms for EUS are poised for high growth.
Cost-Effective Solutions for Emerging Markets: There is a clear market need for affordable, easy-to-use EUS systems in developing countries. Portable and lower-cost alternatives could unlock vast untapped demand.
Interventional EUS Accessories: As therapeutic EUS expands, the demand for specialized accessories such as LAMS, guidewires, and dedicated stents will grow rapidly.
Training and Education Services: The shortage of skilled endoscopists presents an opportunity for companies offering training programs and simulation-based education, which can also serve as a channel to build brand loyalty.
Import/Export and Trade Dynamics
The EUS market is global, with significant cross-border trade in finished devices and components. Major manufacturing hubs include the United States, Japan, and Europe, which export to the rest of the world. Emerging markets in Asia Pacific and Latin America are primarily importers of EUS systems.
Trade Regulations: Tariffs and regulatory approvals (e.g., FDA, CE Mark) significantly influence market access and pricing.
Supply Chain Resilience: The COVID-19 pandemic exposed vulnerabilities in global supply chains, prompting manufacturers to consider regional diversification and inventory buffering.
After-Sales Services: A substantial portion of revenue comes from after-sales services, including maintenance contracts and software upgrades, which are less sensitive to trade fluctuations.
Table 21: Asia Pacific Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Product 2020 & 2034
Table 22: Asia Pacific Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Application 2020 & 2034
Table 23: Asia Pacific Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by End Use 2020 & 2034
Table 24: Asia Pacific Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Country 2020 & 2034
Table 25: China Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 26: Japan Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 27: India Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 28: South Korea Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 29: Australia Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 30: Latin America Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Product 2020 & 2034
Table 31: Latin America Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Application 2020 & 2034
Table 32: Latin America Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by End Use 2020 & 2034
Table 33: Latin America Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Country 2020 & 2034
Table 34: Brazil Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 35: Argentina Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 36: Middle East & Africa Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Product 2020 & 2034
Table 37: Middle East & Africa Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Application 2020 & 2034
Table 38: Middle East & Africa Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by End Use 2020 & 2034
Table 39: Middle East & Africa Endoscopic Ultrasound (EUS) Market Revenue Billion Forecast, by Country 2020 & 2034
Table 40: South Africa Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 41: Saudi Arabia Endoscopic Ultrasound (EUS) Market Revenue (Billion) Forecast, by Application 2020 & 2034
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
Our primary research relies on exhaustive interviews with over 1,200 industry stakeholders across the endoscopic ultrasound value chain, including component manufacturers, device OEMs, hospital procurement heads, and interventional gastroenterologists.
We employ a 70/30 split between primary and secondary research, ensuring that our market estimates are grounded in real-world clinical and commercial insights.
Interviews are conducted across 25 countries, with a focus on high-growth regions such as Asia Pacific and Latin America.
Data is collected via structured questionnaires, in-depth discussions, and observational visits to endoscopy centers to understand procedural volumes and device usage patterns.
Primary research participants include:
Company Types: Endoscope and ultrasound processor OEMs (30%), Needle and accessory manufacturers (25%), Distributed and component suppliers (20%), Healthcare providers (hospitals and ASCs) (15%), and Regulatory/consulting firms (10%).
We triangulate primary data with rigorous secondary research from official multilateral institutions and trade associations, including the World Health Organization (WHO), International Agency for Research on Cancer (IARC), and national cancer registries.
Financial databases such as Bloomberg, Factiva, Hoovers, and PitchBook are used to analyze company financials, M&A activity, and investment trends.
Industry benchmarks are sourced from recognized non-profit technical societies, such as the American Society for Gastrointestinal Endoscopy (ASGE) and the European Society of Gastrointestinal Endoscopy (ESGE), to validate procedural volumes and technology adoption rates.
All secondary data is cross-verified against our proprietary primary research findings to ensure accuracy and relevance.
Demand Modeling & Market Estimation
We employ a simultaneous top-down and bottom-up approach to market sizing, validated via multi-level data triangulation.
The bottom-up model is built on granular procedural volume data, including:
Number of EUS procedures performed annually by region and indication (e.g., pancreatic cancer staging, lung cancer staging).
Average selling price (ASP) of EUS systems and accessories, adjusted for regional pricing variations.
Replacement rates for echoendoscopes and processors, typically every 5-7 years.
The top-down model leverages macroeconomic indicators, healthcare expenditure, and cancer incidence rates to estimate total addressable market.
Demand modeling incorporates factors such as the adoption rate of interventional EUS, the availability of trained endoscopists, and reimbursement policies.
Our proprietary forecast models integrate real-time market signals, including product launches, regulatory approvals, and clinical guideline updates.
Data Accuracy & Quality Check
Our research process guarantees an estimated data accuracy level of 85–90%, ensured through a rigorous multi-stage validation process.
All data points are subject to at least three rounds of internal review and cross-validation by senior analysts.
We conduct sanity checks by comparing our estimates with official trade statistics from organizations like UN Comtrade and the World Bank, where applicable.
Every report is updated to the date of purchase, ensuring that our clients receive the most current market intelligence.
Our quality assurance team audits the final deliverables for consistency, coherence, and compliance with our proprietary methodology standards.
Frequently Asked Questions
1. What is the current market size of the endoscopic ultrasound (EUS) market?
The global EUS market was valued at USD 1.6 billion in 2025 and is expected to reach USD 2.8 billion by 2033.
2. What is the growth rate (CAGR) of the EUS market?
The market is projected to grow at a CAGR of 7.1% from 2026 to 2033, driven by rising cancer incidence and technological advancements.
3. Which region dominates the endoscopic ultrasound market?
North America holds the largest market share, accounting for 31.0% of global revenue in 2025, due to advanced healthcare infrastructure and high adoption rates.
4. Who are the key players in the EUS market?
Leading companies include Olympus Corporation, Fujifilm Corporation, Boston Scientific Corporation, Pentax Medical, Cook Medical, and Medtronic, among others.
5. What are the main applications of endoscopic ultrasound?
EUS is primarily used for diagnosing and staging gastrointestinal and lung cancers, pancreaticobiliary diseases, and for guiding interventional procedures like fine-needle aspiration and drainage.
.jpg){kind=small}
